Previous Page  3 / 8 Next Page
Information
Show Menu
Previous Page 3 / 8 Next Page
Page Background

Page 27

allied

academies

Journal of Medical Oncology & Therapeutics | Volume 4

March 18-19, 2019 | London, UK

Oncology & Cancer Therapy

International Conference on

Notes:

Novel surgical options in breast cancer

Diane M Radford

Cleveland Clinic Foundation, USA

T

his talk focuses on advances in oncoplastic surgery

techniques for breast cancer, and surgical methods to

reduce lymphedema.

Nipple-sparing mastectomy (NSM) in the United States was

first described by Drs. Joseph Crowe and Randall Yetman of

the Cleveland Clinic (CCF) in 2004. Incision placement for the

procedure can be inframammary, periareolar, lateral, upper

outer quadrant, lateral with a periareolar extension, medial,

and transareolar. When the tumor is superficial in location,

preserving the skin anterior to the tumor can compromise

the oncologic goal of clear margins. The technique of Tumor

Ultrasound-guided Incision (TUGI) for NSM developed by Dr.

Stephen Grobmyer and colleagues at CCF overcomes this

problem.

The techniques employs intraoperative ultrasound to locate

the tumor and delineate the skin overlying it. The incision is

then based on the tumor location, removing the skin anterior

to the tumor en bloc with the NSM. This approach balances

oncologic safety and technical outcomes.

Lymphedema is the nemesis of axillary nodal surgery for

breast cancer, impacting patient quality of life and resulting

in significant functional, psychological, and social morbidity.

Although the increased use of sentinel node biopsy, either

when nodes are clinically negative, or following neo-adjuvant

therapy (NAC), has resulted in lower lymphedema rates, the

rates following full axillary dissection can be up to 77%.

Techniques to reduce lymphedema include axillary reverse

mapping (ARM), meticulous dissection of arm lymphatics

with loupe magnification, microsurgical lymphaticovenous

bypass, and a triple mapping technique following NAC which

incorporates Indocyanine Green (ICG) fluorescence for

sentinel node bypass.

Speaker Biography

Diane M Radford is a staff breast surgical oncologist with the Cleveland Clinic in Cleveland,

Ohio, and Director of the Breast Program at Cleveland Clinic Hillcrest Hospital. Originally

from Scotland, she trained on both sides of the Atlantic, including the Professorial Unit,

Royal Infirmary of Edinburgh, the Western Infirmary, Glasgow, and St. Louis University.

She has completed fellowships in Surgical Oncology (Roswell Park Cancer Institute) and

IntegrativeMedicine(UniversityofArizona).HerpeershaverecognizedherasaBestDoctor

every year since 1996 as well as a Top Doctor nationally. She has authored numerous peer-

reviewed journal articles and textbook chapters. Active on social media since 2011, she

has lectured nationally and internationally on social media for health care professionals

including at the Harvard course “Achieving Healthcare Leadership and Outcomes Through

Writing, Publishing, and Social Media,” and at the American Society of Breast Surgeons

annual meeting. She participates in the tweet chat #bcsm (breast cancer social media) and

has been featured as a guest expert. She serves on the Editorial Board of the Annals of

Surgical Oncology, Multi-Media section, and co-authored a guide for other members of the

board on how to use Twitter. Her Twitter followers number over 15,000.

e

:

dmradford57@hotmail.com